Ranked by engagement

Top topics — this year page 14

Ranked by replies, likes and views over this year, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.

This week This month This quarter This year All time

1,076 topics · page 14 of 14

Topic	Participants	Replies	Views	Activity
How shortages have affected compounding permissions Access › Shortages shortage compounding FDA formulary How shortages have affected compounding permissions I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to know what people here actually do about shortages,…	+61	71	3.6k	2d
Aggregate verification data across the directory, with caveats Sourcing › Independent verification Medutest blind sampling PeptideMeter Under review On the subject in the title: Aggregate verification data across the directory, with caveats Working notes rather than a conclusion. I have spent a fortnight trying to pin aggregate verification data down and…	+64	74	4.6k	14h
Follow-up: Reading an interaction checker output critically Practice › Interactions insulin hypoglycaemia delayed gastric emptying needs a source Solved Reading an interaction checker output critically — setting out what I have, and where I think it stops being reliable. A follow-up question about Reading an interaction checker output that I did not know to…	+62	66	13k	2d
Reused chromatograms across lots: how to spot it Analytics › COA interpretation batch & lot numbers amino acid analysis documentation quality certificate of analysis On the subject in the title: Reused chromatograms across lots: how to spot it Working notes rather than a conclusion. Something about reused chromatograms across lots does not reconcile and I would like a…	+53	60	9.5k	4h
Splitting a weekly dose in two: the pharmacokinetic argument against Practice › Dosing & titration titration tirzepatide semaglutide missed dose Splitting a weekly dose in two: the pharmacokinetic argument against — setting out what I have, and where I think it stops being reliable. I have read the maintained page on this and I still have a gap, so I…	+24	28	51k	5mo
Why the Start Here categories exist, and what they are not for Start Here › Welcome guidelines trust levels onboarding beginner friendly Solved Why the Start Here categories exist, and what they are not for — that is the question, and I have not found it answered plainly anywhere I have looked. Collecting what is known about Start in one place,…	+40	44	32k	1d
Chain of custody for a sample you posted yourself — one year on Sourcing › Independent verification VendorInvestigate Janoshik Analytical blind sampling third-party testing Posting this under the heading it deserves: Chain of custody for a sample you posted yourself — one year on Everything below is what sits behind that. Posting a small dataset on Chain of custody. It is mine,…	+28	32	50k	15h
Coming back to: A community side-effect dataset, with its response rate and biases Data & Tools › Datasets observational data site feedback confounding data table On the subject in the title: A community side-effect dataset, with its response rate and biases Working notes rather than a conclusion. Reading back through what has been written here about community…	+27	31	46k	9mo
A checklist for reading a certificate in under two minutes — does this still hold? Analytics › COA interpretation documentation quality certificate of analysis amino acid analysis batch & lot numbers Solved A checklist for reading a certificate in under two minutes — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to understand what this…	+49	55	15k	9mo
Criticising the method without criticising the authors — one year on Evidence › Study critique confounding effect size disputed risk of bias Solved Closed On the subject in the title: Criticising the method without criticising the authors — one year on Working notes rather than a conclusion. A methods question rather than a substantive one, about Criticising…	+16	20	61k	11mo
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Compounds › Retatrutide retatrutide preprint randomised trial effect size Solved The question in the title: Why a glucagon receptor agonist in a weight-loss compound is not a contradiction I will give what I have already checked below so nobody repeats it. I would like to disagree…	+43	47	19k	2d
Revisiting: Primary endpoint hierarchies and why order matters Evidence › Trials estimand surrogate endpoints discontinuation & dropout intention to treat Posting this under the heading it deserves: Revisiting: Primary endpoint hierarchies and why order matters Everything below is what sits behind that. I was wrong about Primary endpoint hierarchies in a thread…	+21	25	46k	3mo
Packaging that arrived damaged: documenting it properly Sourcing › Logistics shipping customs temperature excursion cold chain Pinned Packaging that arrived damaged: documenting it properly Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the answers here are usually better than…	+43	49	26k	1d
Review: a draft on reconstitution arithmetic, with objections — one year on Documentation › Doc review maintainership citation check promoted to docs review date Review: a draft on reconstitution arithmetic, with objections — one year on Writing it up because I had to work it out twice and would rather nobody else did. The question about draft on reconstitution…	+46	51	11k	20h
Revisiting: Journal club: SURMOUNT-1, read without the press release Evidence › Journal club number needed to treat effect size risk of bias journal club Solved On the subject in the title: Revisiting: Journal club: SURMOUNT-1, read without the press release Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please read it…	+54	62	1.5k	26d
[2026 update] Currency conversion and the cost you did not see Sourcing › Payments research use only payments documentation quality Solved Posting this under the heading it deserves: Currency conversion and the cost you did not see Everything below is what sits behind that. Currency and fees, set out so that the comparison can be checked. Quoted…	+21	26	52k	2d
EU-wide position versus national implementation — what changed since Regional › European Union EMA cost per milligram personal import formulary Pinned EU-wide position versus national implementation — what changed since Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of eu-wide position…	+22	26	58k	2mo
Shakes versus food: a pragmatic assessment Nutrition & Training › Protein & intake lean mass loss micronutrients constipation Shakes versus food: a pragmatic assessment Writing it up because I had to work it out twice and would rather nobody else did. I would like to know what people here actually do about shakes versus food, as…	+22	26	53k	20h
Revisiting: List price versus negotiated price versus what you pay Access › Pricing cost per milligram compounding data table formulary Revisiting: List price versus negotiated price versus what you pay — setting out what I have, and where I think it stops being reliable. Working notes on List price versus negotiated price rather than a…	+24	28	50k	12mo
Aggregates and why a purity assay may miss them entirely Analytics › Impurities & related substances water content counter-ion content forced degradation HPLC Aggregates and why a purity assay may miss them entirely Writing it up because I had to work it out twice and would rather nobody else did. I would like to disagree carefully with the settled view on…	+61	69	2.9k	6mo
NHS criteria and how they are applied in practice Regional › UK & Ireland NHS cost per milligram personal import MHRA NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. I was wrong about NHS criteria in a thread last spring and I would like to correct it…	+37	42	31k	2d
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Analytics › HPLC & UHPLC gradient method UV & DAD detection peak integration data table On the subject in the title: Area percent versus weight percent: the confusion that causes most arguments Working notes rather than a conclusion. Proposing that Area percent versus weight percent deserves a…	+65	70	1.1k	16d
What changed in 2026, by region — does this still hold? Access › International personal import MHRA EMA telehealth Solved What changed in 2026, by region — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated, because everything in…	+20	25	50k	1d
An emergency department visit, described afterwards Safety › Adverse events gallbladder hypoglycaemia pancreatitis An emergency department visit, described afterwards Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated before anyone answers on emergency…	+56	62	1.4k	11mo
A structured critique template this community uses — a second dataset Evidence › Study critique observational data effect size confounding Solved On the subject in the title: A structured critique template this community uses — a second dataset Working notes rather than a conclusion. Posting a small dataset on structured critique template. It is mine,…	+47	51	16k	15h
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Practice › Administration subcutaneous injection aseptic technique needle gauge & length injection site reaction Closed Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this…	+16	20	56k	12mo
Second pass at: Robustness: the parameters worth deliberately varying Analytics › Method validation linearity LOD & LOQ recovery system suitability On the subject in the title: Second pass at: Robustness: the parameters worth deliberately varying Working notes rather than a conclusion. Something about Robustness does not reconcile and I would like a…	+61	66	9.5k	3mo
Follow-up: A parcel that arrived warm: a decision process, not a verdict Practice › Storage & stability temperature excursion cloudy or discoloured solution beyond-use date Posting this under the heading it deserves: A parcel that arrived warm: a decision process, not a verdict Everything below is what sits behind that. Asking about the failure mode rather than the procedure,…	+49	59	1.2k	2mo
Revisiting: Review: an evidence digest and the citation check that delayed it Documentation › Doc review citation check review date maintainership Solved Closed Revisiting: Review: an evidence digest and the citation check that delayed it — setting out what I have, and where I think it stops being reliable. Proposing that evidence digest deserves a maintained page…	+54	58	8.2k	5mo
Ultrasound and skinfolds: operator dependence in practice Outcomes › Body composition DXA data table lean mass loss Ultrasound and skinfolds: operator dependence in practice — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on ultrasound and skinfolds. The…	+72	76	2.7k	2d